Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine

Takeshi Enomoto, Yukihiro Noda, Akihiro Mouri, Eun Joo Shin, Dayong Wang, Rina Murai, Kazuo Hotta, Hiroshi Furukawa, Atsumi Nitta, Hyoung Chun Kim, Toshitaka Nabeshima

研究成果: Article

39 引用 (Scopus)

抄録

In humans, the administration of phencyclidine causes schizophrenic-like symptoms that persist for several weeks after withdrawal from phencyclidine use. We demonstrated here that mice pretreated with phencyclidine (10 mg/kg/day s.c. for 14 days) showed an enduring impairment of associative in a Pavlovian fear conditioning 8 days after cessation of phencyclidine treatment. Extracellular signaling-regulated kinase (ERK) was transiently activated in the amygdalae and hippocampi of saline-treated mice after conditioning. In the phencyclidinetreated mice, the basal level of ERK activation was elevated in the hippocampus, whereas the activation was impaired in the amygdala and hippocampus after conditioning. Exogenous N-methyl-D-aspartate (NMDA), glycine, and spermidine-induced ERK activation was not observed in slices of hippocampus and amygdala prepared from phencyclidine-treated mice. Repeated olanzapine (3 mg/kg/day p.o. for 7 days), but not haloperidol (1 mg/kg/day p.o. for 7 days), treatment reversed the impairment of associative learning and of fear conditioning-induced ERK activation in repeated phencyclidine-treated mice. Our findings suggest an involvement of abnormal ERK signaling via NMDA receptors in repeated phencyclidine treatment-induced cognitive dysfunction. Furthermore, our phencyclidine-treated mice would be a useful model for studying the effect of antipsychotics on cognitive dysfunction in schizophrenia.

元の言語English
ページ(範囲)1765-1774
ページ数10
ジャーナルMolecular Pharmacology
68
発行部数6
DOI
出版物ステータスPublished - 01-12-2005
外部発表Yes

Fingerprint

Phencyclidine
N-Methylaspartate
Phosphotransferases
Learning
Hippocampus
Amygdala
olanzapine
Fear
Withholding Treatment
Spermidine
Haloperidol
N-Methyl-D-Aspartate Receptors
Glycine
Antipsychotic Agents
Schizophrenia
Conditioning (Psychology)
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

これを引用

Enomoto, Takeshi ; Noda, Yukihiro ; Mouri, Akihiro ; Shin, Eun Joo ; Wang, Dayong ; Murai, Rina ; Hotta, Kazuo ; Furukawa, Hiroshi ; Nitta, Atsumi ; Kim, Hyoung Chun ; Nabeshima, Toshitaka. / Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine. :: Molecular Pharmacology. 2005 ; 巻 68, 番号 6. pp. 1765-1774.
@article{7750b261c34a48f7a3876ba460f7c6fa,
title = "Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine",
abstract = "In humans, the administration of phencyclidine causes schizophrenic-like symptoms that persist for several weeks after withdrawal from phencyclidine use. We demonstrated here that mice pretreated with phencyclidine (10 mg/kg/day s.c. for 14 days) showed an enduring impairment of associative in a Pavlovian fear conditioning 8 days after cessation of phencyclidine treatment. Extracellular signaling-regulated kinase (ERK) was transiently activated in the amygdalae and hippocampi of saline-treated mice after conditioning. In the phencyclidinetreated mice, the basal level of ERK activation was elevated in the hippocampus, whereas the activation was impaired in the amygdala and hippocampus after conditioning. Exogenous N-methyl-D-aspartate (NMDA), glycine, and spermidine-induced ERK activation was not observed in slices of hippocampus and amygdala prepared from phencyclidine-treated mice. Repeated olanzapine (3 mg/kg/day p.o. for 7 days), but not haloperidol (1 mg/kg/day p.o. for 7 days), treatment reversed the impairment of associative learning and of fear conditioning-induced ERK activation in repeated phencyclidine-treated mice. Our findings suggest an involvement of abnormal ERK signaling via NMDA receptors in repeated phencyclidine treatment-induced cognitive dysfunction. Furthermore, our phencyclidine-treated mice would be a useful model for studying the effect of antipsychotics on cognitive dysfunction in schizophrenia.",
author = "Takeshi Enomoto and Yukihiro Noda and Akihiro Mouri and Shin, {Eun Joo} and Dayong Wang and Rina Murai and Kazuo Hotta and Hiroshi Furukawa and Atsumi Nitta and Kim, {Hyoung Chun} and Toshitaka Nabeshima",
year = "2005",
month = "12",
day = "1",
doi = "10.1124/mol.105.011304",
language = "English",
volume = "68",
pages = "1765--1774",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine. / Enomoto, Takeshi; Noda, Yukihiro; Mouri, Akihiro; Shin, Eun Joo; Wang, Dayong; Murai, Rina; Hotta, Kazuo; Furukawa, Hiroshi; Nitta, Atsumi; Kim, Hyoung Chun; Nabeshima, Toshitaka.

:: Molecular Pharmacology, 巻 68, 番号 6, 01.12.2005, p. 1765-1774.

研究成果: Article

TY - JOUR

T1 - Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine

AU - Enomoto, Takeshi

AU - Noda, Yukihiro

AU - Mouri, Akihiro

AU - Shin, Eun Joo

AU - Wang, Dayong

AU - Murai, Rina

AU - Hotta, Kazuo

AU - Furukawa, Hiroshi

AU - Nitta, Atsumi

AU - Kim, Hyoung Chun

AU - Nabeshima, Toshitaka

PY - 2005/12/1

Y1 - 2005/12/1

N2 - In humans, the administration of phencyclidine causes schizophrenic-like symptoms that persist for several weeks after withdrawal from phencyclidine use. We demonstrated here that mice pretreated with phencyclidine (10 mg/kg/day s.c. for 14 days) showed an enduring impairment of associative in a Pavlovian fear conditioning 8 days after cessation of phencyclidine treatment. Extracellular signaling-regulated kinase (ERK) was transiently activated in the amygdalae and hippocampi of saline-treated mice after conditioning. In the phencyclidinetreated mice, the basal level of ERK activation was elevated in the hippocampus, whereas the activation was impaired in the amygdala and hippocampus after conditioning. Exogenous N-methyl-D-aspartate (NMDA), glycine, and spermidine-induced ERK activation was not observed in slices of hippocampus and amygdala prepared from phencyclidine-treated mice. Repeated olanzapine (3 mg/kg/day p.o. for 7 days), but not haloperidol (1 mg/kg/day p.o. for 7 days), treatment reversed the impairment of associative learning and of fear conditioning-induced ERK activation in repeated phencyclidine-treated mice. Our findings suggest an involvement of abnormal ERK signaling via NMDA receptors in repeated phencyclidine treatment-induced cognitive dysfunction. Furthermore, our phencyclidine-treated mice would be a useful model for studying the effect of antipsychotics on cognitive dysfunction in schizophrenia.

AB - In humans, the administration of phencyclidine causes schizophrenic-like symptoms that persist for several weeks after withdrawal from phencyclidine use. We demonstrated here that mice pretreated with phencyclidine (10 mg/kg/day s.c. for 14 days) showed an enduring impairment of associative in a Pavlovian fear conditioning 8 days after cessation of phencyclidine treatment. Extracellular signaling-regulated kinase (ERK) was transiently activated in the amygdalae and hippocampi of saline-treated mice after conditioning. In the phencyclidinetreated mice, the basal level of ERK activation was elevated in the hippocampus, whereas the activation was impaired in the amygdala and hippocampus after conditioning. Exogenous N-methyl-D-aspartate (NMDA), glycine, and spermidine-induced ERK activation was not observed in slices of hippocampus and amygdala prepared from phencyclidine-treated mice. Repeated olanzapine (3 mg/kg/day p.o. for 7 days), but not haloperidol (1 mg/kg/day p.o. for 7 days), treatment reversed the impairment of associative learning and of fear conditioning-induced ERK activation in repeated phencyclidine-treated mice. Our findings suggest an involvement of abnormal ERK signaling via NMDA receptors in repeated phencyclidine treatment-induced cognitive dysfunction. Furthermore, our phencyclidine-treated mice would be a useful model for studying the effect of antipsychotics on cognitive dysfunction in schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=27844483411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844483411&partnerID=8YFLogxK

U2 - 10.1124/mol.105.011304

DO - 10.1124/mol.105.011304

M3 - Article

VL - 68

SP - 1765

EP - 1774

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -